- Arcturus Therapeutics (NASDAQ:ARCT) has appointed Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and Development, effective immediately.
- Dr. Esau prior to joining Arcturus in 2015, was lead biologist at Ionis Pharmaceuticals and Regulus Therapeutics and served as Chief Scientific Officer of AptamiR Therapeutics.
- Also, Dr. Pad Chivukula is stepping down as Chief Scientific Officer and Chief Operating Officer and will serve as a Scientific Advisor to the Company.